Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

Tea tree oil and silver effective in treating skin infections

In the fight against infected skin wounds, mixing tea tree oil and silver or putting them in liposomes, (small spheres made from natural lipids), greatly increases their antimicrobial activity and may minimise any side effects.

30 Mar 2009

Concern over inappropriate diagnosis and treatment of primary hypothyroidism

More and more people are being inappropriately diagnosed and treated for underactivity of the thyroid gland (known as primary hypothyroidism), warn doctors in an editorial published on bmj.com today.

29 Mar 2009

More cancer patients cured according to new data on cancer survival in Europe

New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer - rather than just surviving for at least five years after diagnosis - is rising steadily.

23 Mar 2009

Prostate cancer expert say keep screening in face of contradicting data

New data evaluating the impact of screening on mortality provides mixed messages on the value of prostate cancer screening.

20 Mar 2009

Continued HIV/AIDS progress could lead to increased life expectancy, population among developing countries, U.N. report says

Life expectancy in developing countries could increase to 69 years by 2050 if the global health community sustains progress in controlling HIV/AIDS and other infectious diseases, according to a report released Wednesday by the United Nations Population Division, Montreal's Gazette reports (Edwards, Gazette, 3/12).

16 Mar 2009

Immune cells play surprising role in cystic fibrosis lung damage

Immune cells once thought to be innocent bystanders in cystic fibrosis may hold the key to stopping patients' fatal lung disease.

16 Mar 2009

Treatment of European coronary patients fails to meet standards of international guidelines

Large proportions of European coronary patients are failing to achieve lifestyle, risk factor and therapeutic targets for the prevention of further disease, according to results of the third EUROASPIRE survey.

12 Mar 2009

Hypertension linked to earlier death among African-American breast cancer patients

A study by researchers at the University of California, San Francisco has shown that hypertension, or high blood pressure, is a predictor of mortality among breast cancer patients, especially those who are African-American, and that hypertension accounts for approximately 30 percent of the survival disparity between African-American and white breast cancer patients.

4 Mar 2009

Increasing risk of HIV among seniors

People ages 50 and older are more likely to have unprotected sex than younger groups, increasing their risk for HIV and other sexually transmitted infections, according to a recently released World Health Organization study, Reuters UK reports.

4 Mar 2009

A second MND gene mutation in one year signifies rapid research progress

A collaborative research project involving Professor Christopher Shaw of the Institute of Psychiatry, King's College London (KCL), Dr Tom Kwiatkowski at Massachusetts General Hospital (MGH) and Professor Robert H Brown at University of Massachusetts, has revealed that mutations in a gene called FUS (fused in sarcoma) cause familial Motor Neuron Disease (also known as Amyotrophic Lateral Sclerosis).

26 Feb 2009

Medivation announces new positive efficacy data from trial of MDV3100 in Castration-resistant prostate cancer

Medivation, Inc. has announced the presentation of new efficacy and safety data from an ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist MDV3100 in castration-resistant prostate cancer (CRPC) patients.

25 Feb 2009

Breakthrough in human papillomavirus research

UAB (University of Alabama at Birmingham) researchers have developed a new, inexpensive and efficient method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer.

23 Feb 2009

FOXO3A gene variation may be key to longer life

A variation in the gene FOXO3A has a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond - moreover, this appears to be true worldwide.

3 Feb 2009

First genetic map of obesity

The first genetic map of obesity has been constructed using DNA microarray technology.

21 Jan 2009

Invatec launches drug-eluting balloon to treat atherosclerosis below the knee

Invatec, a comprehensive innovator of interventional products, today announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter.

15 Jan 2009

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).

15 Jan 2009

New online tool to evaluate health reform proposals

The RAND Corporation today launched an online tool to provide policymakers and interested parties with a unique way of understanding and evaluating the effects and unintended consequences of health care reform proposals certain to be introduced in the new 111th Congress and beyond.

13 Jan 2009

An explanation of how statins cause low rates of muscle symptoms

In the January 2009 issue of the American Journal of Medicine , Florida Atlantic University researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science and a renowned expert who has revealed numerous causal, therapeutic and preventive factors in the treatment and prevention of cardiovascular disease (CVD), most notably low-dose aspirin, explains why statins cause low rates of muscle symptoms.

9 Jan 2009

Mortality rates higher for heart disease patients in neighbourhoods with poor socioeconomics status

Heart disease patients living in poorer areas of B.C. are up to twice as likely to die from chronic diseases than patients living in better-off areas, a University of British Columbia study has found.

8 Jan 2009

Pap test procedure facts

January is Cervical Cancer Awareness Month and The University of Texas M. D. Anderson Cancer Center shares important information about the cervical cancer screening exam, the Pap test.

7 Jan 2009